Literature DB >> 11454645

Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.

A R Lorenzi1, A H Johnson, G Davies, A Gough.   

Abstract

A case of severe, transfusion dependent anaemia in a 72 year old woman, which on endoscopy was found to be due to gastric antral vascular ectasia (GAVE), is reported. Repeated endoscopic sclerotherapy was ineffective. She subsequently developed Raynaud's phenomenon and on further investigation was found to have classical systemic sclerosis with lung involvement. Treatment with pulses of intravenous methylprednisolone and cyclophosphamide resulted in significant improvement in her pulmonary function tests and skin score. Coincidentally, her haemoglobin stabilised and further endoscopic examinations were normal. This is the first report of cyclophosphamide and methylprednisolone leading to complete and sustained resolution of GAVE in association with systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454645      PMCID: PMC1753805          DOI: 10.1136/ard.60.8.796

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Cyclophosphamide: a novel treatment of gastric antral vascular ectasia associated with systemic sclerosis?

Authors:  Alicia Peterson; John Varga
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

Review 2.  Pharmacological therapy of vascular malformations of the gastrointestinal tract.

Authors:  Andrew Szilagyi; Maged P Ghali
Journal:  Can J Gastroenterol       Date:  2006-03       Impact factor: 3.522

3.  Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.

Authors:  Emily W Hung; Maureen D Mayes; Roozbeh Sharif; Shervin Assassi; Victor I Machicao; Chitra Hosing; E William St Clair; Daniel E Furst; Dinesh Khanna; Stephen Forman; Shin Mineishi; Kristine Phillips; James R Seibold; Christopher Bredeson; Mary Ellen Csuka; Richard A Nash; Mark H Wener; Robert Simms; Karen Ballen; Sharon Leclercq; Jan Storek; Ellen Goldmuntz; Beverly Welch; Lynette Keyes-Elstein; Sharon Castina; Leslie J Crofford; Peter Mcsweeney; Keith M Sullivan
Journal:  J Rheumatol       Date:  2013-02-15       Impact factor: 4.666

4.  Diagnosis and management of gastric antral vascular ectasia.

Authors:  Lorenzo Fuccio; Alessandro Mussetto; Liboria Laterza; Leonardo Henry Eusebi; Franco Bazzoli
Journal:  World J Gastrointest Endosc       Date:  2013-01-16

5.  Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease.

Authors:  Masahiro Hirayama; Eiichi Azuma; Atsuko Nakazawa; Shotaro Iwamoto; Hidemi Toyoda; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2013-02-03       Impact factor: 2.490

6.  Nd:YAG laser induces long-term remission in transfusion-dependent patients with watermelon stomach.

Authors:  N G Mathou; L B Lovat; S M Thorpe; S G Bown
Journal:  Lasers Med Sci       Date:  2004-01-15       Impact factor: 3.161

Review 7.  Gastric Antral Vascular Ectasia Pathogenesis and the Link to the Metabolic Syndrome.

Authors:  Elliot Smith; Jessica Davis; Stephen Caldwell
Journal:  Curr Gastroenterol Rep       Date:  2018-07-02

8.  Gastric Antral Vascular Ectasia: Trends of Hospitalizations, Biodemographic Characteristics, and Outcomes With Watermelon Stomach.

Authors:  Asim Kichloo; Dhanshree Solanki; Jagmeet Singh; Dushyant Singh Dahiya; Darshan Lal; Khwaja Fahad Haq; Michael Aljadah; Darshan Gandhi; Shantanu Solanki; Hafiz Muzaffar Akbar Khan
Journal:  Gastroenterology Res       Date:  2021-04-21

9.  Gastric antral vascular ectasia in systemic sclerosis.

Authors:  Jill Johnson; Chris T Derk
Journal:  Int J Rheumatol       Date:  2011-11-02

Review 10.  Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review.

Authors:  Mengyuan Peng; Xiaozhong Guo; Fangfang Yi; Fernando Gomes Romeiro; Andrea Mancuso; Xingshun Qi
Journal:  Adv Ther       Date:  2021-09-15       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.